The first-line treatment for an acute malignant hyperthermia crisis is dantrolene, a muscle relaxant that inhibits calcium release from the sarcoplasmic reticulum. Alongside administering dantrolene, supportive measures include cooling the patient, providing 100% oxygen, and correcting metabolic acidosis with intravenous bicarbonate.
